Blended therapy for adolescents with chronic health conditions to increase fatigue-related self-efficacy (Booster): protocol for a single-case multiple baseline study.

IF 2 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Trials Pub Date : 2025-07-24 DOI:10.1186/s13063-025-08960-1
Maartje D Stutvoet, Anouk Vroegindeweij, Jan Houtveen, Raphaële R L van Litsenburg, Elise van de Putte, Remco C Veltkamp, Sanne L Nijhof
{"title":"Blended therapy for adolescents with chronic health conditions to increase fatigue-related self-efficacy (Booster): protocol for a single-case multiple baseline study.","authors":"Maartje D Stutvoet, Anouk Vroegindeweij, Jan Houtveen, Raphaële R L van Litsenburg, Elise van de Putte, Remco C Veltkamp, Sanne L Nijhof","doi":"10.1186/s13063-025-08960-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fatigue is a common symptom in adolescents with a chronic health condition. Persistent fatigue and its impairments may be prevented by early intervention with Booster. Booster is a transdiagnostic blended care intervention that aims to increase fatigue-related self-efficacy (FSE). Through experience sampling methodology (ESM) via the Booster smartphone app, Booster helps users gain personalised insight into the relationship between their thoughts, feelings, activities, and fatigue. Based on this insight and shared-decision making, the participant and executive investigator set personal lifestyle goals, such as more exercise and fewer daytime naps. The previous version of Booster, PROfeel, has already been shown effective in treating persistent fatigue in youth. Booster's value as an early intervention has yet to be studied. To better suit this aim and align with user preferences, the new Booster app includes features like goal attainment assistance, daily outcome tracking, and motivating game mechanics (e.g., rewards and a minigame). This protocol describes a study to examine the effect of Booster on FSE and the other study outcomes fatigue, school participation, life satisfaction, and perceived health. The secondary aim is to explore individual differences regarding (moment of) changes in outcomes during the Booster intervention.</p><p><strong>Methods: </strong>It is a single-centre study with a multiple baseline single-case experimental design (SCED). We aim to include twenty adolescents ages 12 to 18 years with a chronic health condition and fatigue. Booster's effect on outcomes will be measured with a daily survey during Phase A (baseline) and B (intervention). The start of phase B will be randomised across cases. The effect will be assessed with the multiple baseline single-case randomisation test (SCRT) at the group level. Additionally, at the single-case level, we will explore change using permutation distancing tests (PDTs), single-case interrupted time series analysis (ITSA), and change point analyses. Also, we will assess participant characteristics associated with (long-term) improvements.</p><p><strong>Discussion: </strong>Booster uses innovative methods by combining tailored ESM-insight, mHealth and healthcare professional support. Group-level analysis, strengthened by single-case observational analyses, will evaluate the effectiveness of ESM-supported blended care as an early fatigue intervention and identify its potential working mechanisms. It lays the groundwork for implementing ESM tools in clinical practice.</p><p><strong>Trial registration: </strong>ClinicalTrials, NCT06562335. Registered on 24 July 2024, https://clinicaltrials.gov/study/NCT06562335 .</p>","PeriodicalId":23333,"journal":{"name":"Trials","volume":"26 1","pages":"255"},"PeriodicalIF":2.0000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12291284/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13063-025-08960-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fatigue is a common symptom in adolescents with a chronic health condition. Persistent fatigue and its impairments may be prevented by early intervention with Booster. Booster is a transdiagnostic blended care intervention that aims to increase fatigue-related self-efficacy (FSE). Through experience sampling methodology (ESM) via the Booster smartphone app, Booster helps users gain personalised insight into the relationship between their thoughts, feelings, activities, and fatigue. Based on this insight and shared-decision making, the participant and executive investigator set personal lifestyle goals, such as more exercise and fewer daytime naps. The previous version of Booster, PROfeel, has already been shown effective in treating persistent fatigue in youth. Booster's value as an early intervention has yet to be studied. To better suit this aim and align with user preferences, the new Booster app includes features like goal attainment assistance, daily outcome tracking, and motivating game mechanics (e.g., rewards and a minigame). This protocol describes a study to examine the effect of Booster on FSE and the other study outcomes fatigue, school participation, life satisfaction, and perceived health. The secondary aim is to explore individual differences regarding (moment of) changes in outcomes during the Booster intervention.

Methods: It is a single-centre study with a multiple baseline single-case experimental design (SCED). We aim to include twenty adolescents ages 12 to 18 years with a chronic health condition and fatigue. Booster's effect on outcomes will be measured with a daily survey during Phase A (baseline) and B (intervention). The start of phase B will be randomised across cases. The effect will be assessed with the multiple baseline single-case randomisation test (SCRT) at the group level. Additionally, at the single-case level, we will explore change using permutation distancing tests (PDTs), single-case interrupted time series analysis (ITSA), and change point analyses. Also, we will assess participant characteristics associated with (long-term) improvements.

Discussion: Booster uses innovative methods by combining tailored ESM-insight, mHealth and healthcare professional support. Group-level analysis, strengthened by single-case observational analyses, will evaluate the effectiveness of ESM-supported blended care as an early fatigue intervention and identify its potential working mechanisms. It lays the groundwork for implementing ESM tools in clinical practice.

Trial registration: ClinicalTrials, NCT06562335. Registered on 24 July 2024, https://clinicaltrials.gov/study/NCT06562335 .

对患有慢性健康状况的青少年进行混合治疗,以提高疲劳相关的自我效能(助推器):一项单例多基线研究的方案。
背景:疲劳是青少年慢性健康状况的常见症状。持续性疲劳及其损伤可通过早期干预预防。Booster是一种跨诊断混合护理干预,旨在提高疲劳相关自我效能(FSE)。通过Booster智能手机应用程序的体验抽样方法(ESM), Booster帮助用户获得个性化的见解,了解他们的思想、感觉、活动和疲劳之间的关系。基于这种见解和共同决策,参与者和执行调查员设定了个人生活方式目标,例如更多的锻炼和更少的白天小睡。先前版本的助推器,PROfeel,已经被证明对治疗年轻人的持续性疲劳有效。助推器作为早期干预的价值还有待研究。为了更好地适应这一目标并与用户偏好保持一致,新的Booster应用程序包含了目标实现辅助,每日结果跟踪和激励游戏机制(如奖励和小游戏)等功能。本方案描述了一项研究,旨在检查Booster对FSE和其他研究结果(疲劳、学校参与、生活满意度和感知健康)的影响。第二个目的是探讨在助推器干预期间(时刻)结果变化的个体差异。方法:采用多基线单病例实验设计(SCED)的单中心研究。我们的目标是包括20名年龄在12至18岁之间的青少年,他们患有慢性健康状况和疲劳。在a阶段(基线)和B阶段(干预)期间,通过每日调查来测量Booster对结果的影响。B阶段的开始将根据病例随机进行。效果将通过组水平的多基线单例随机化试验(SCRT)进行评估。此外,在单个案例层面,我们将使用排列距离测试(pdt)、单个案例中断时间序列分析(ITSA)和变化点分析来探索变化。此外,我们将评估与(长期)改善相关的参与者特征。讨论:Booster采用创新的方法,结合量身定制的esm洞察、移动健康和医疗保健专业支持。小组水平的分析,在单例观察分析的基础上,将评估esm支持的混合护理作为早期疲劳干预的有效性,并确定其潜在的工作机制。它为在临床实践中实施ESM工具奠定了基础。试验注册:ClinicalTrials, NCT06562335。于2024年7月24日注册,https://clinicaltrials.gov/study/NCT06562335。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Trials
Trials 医学-医学:研究与实验
CiteScore
3.80
自引率
4.00%
发文量
966
审稿时长
6 months
期刊介绍: Trials is an open access, peer-reviewed, online journal that will encompass all aspects of the performance and findings of randomized controlled trials. Trials will experiment with, and then refine, innovative approaches to improving communication about trials. We are keen to move beyond publishing traditional trial results articles (although these will be included). We believe this represents an exciting opportunity to advance the science and reporting of trials. Prior to 2006, Trials was published as Current Controlled Trials in Cardiovascular Medicine (CCTCVM). All published CCTCVM articles are available via the Trials website and citations to CCTCVM article URLs will continue to be supported.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信